Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Etinpro (Beijing) Co., Ltd. (also known as Beijing Yizhuang International Protein Drug Technology Co., Ltd. or Beiyi Protein) is a high-tech contract development and manufacturing organization (CDMO) based in the Beijing Yizhuang Biomedical Park. Established in 2012 as a holding subsidiary of Beijing Kawin Technology Share-Holding Co., Ltd., the company specializes in providing one-stop CDMO, CMO, and CRO services for recombinant protein and antibody therapeutics. Etinpro offers comprehensive services ranging from cDNA development to IND filing, including cell line development, process optimization, pilot-scale production, and quality characterization. The company operates state-of-the-art pilot production platforms, including a 500L recombinant protein production line and a 200L antibody drug production line, helping global biopharmaceutical clients accelerate their drug development timelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京亦庄国际蛋白药物技术有限公司.